Cabenuva Ad (ViiV Healthcare)
November 12, 2021 12:39 PM EST
Pharma
Marketing

Glax­o­SmithK­line’s Vi­iV Health­care aims to shift HIV dai­ly pill think­ing in first DTC ads

Beth Snyder Bulik

Senior Editor

For as long as there have been HIV med­i­cines, the on­ly op­tions for pa­tients have been dai­ly pills — un­til this year that is. Glax­o­SmithK­line’s Vi­iV …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

A service from the Financial Times